Search Results - "Noskova, T Yu"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Features of brain electrical activity in adult patients with POLG-related disorders by Fedin, P. A., Nuzhnyi, E. P., Noskova, T. Yu, Seliverstov, Yu. A., Klyushnikov, S. A., Krylova, T. D., Tsygankova, P. G., Zakharova, E. Yu, Illarioshkin, S. N.

    “…Introduction. Epilepsy is a common feature of mitochondrial disorders, including those associated with mutations in the POLG gene. Nevertheless, brain…”
    Get full text
    Journal Article
  2. 2

    The clinical significance of the lamotrigine pharmacokinetic variability by Noskova, T Yu, Abaimov, D A, Sariev, A K, Fedin, P A, Krasnikov, A V, Shvedkov, V V, Sejfulla, R D

    “…To estimate pharmacokinetic variability of lamotrigine (LTG) and its clinical significance. One hundred patients, including 74 women, aged from 18 to 77 years…”
    Get more information
    Journal Article
  3. 3

    DEREALIZATION DISORDERS IN EPILEPSY by P. N. Vlasov, A. V. Chervyakov, G. R. Drozzhina, M. V. Antonyuk, N. V. Orekhova, V. V. Gnezditsky, T. Yu. Noskova, P. A. Fedin

    “…Derealization is mental disorder, manifested in a feeling of unreality and strangeness of the surrounding real world, a form of impairment of consciousness…”
    Get full text
    Journal Article
  4. 4

    THERAPEUTIC DRUG MONITORING OF LAMOTRIGINE: DEVELOPMENT OF PHARMACOKINETIC APPROACHES AIMING AT THE INDIVIDUAL-BASED ANTICONVULSIVE PHARMACOTHERAPY by D. A. Abaimov, A. K. Sariev, M. V. Tankevich, E. Yu. Styrova, V. V. Schvedkov, T. Yu. Noskova, R. D. Seifulla

    “…this paper presents the results of therapeutic drug monitoring of lamotrigine, an anticonvulsant epilepsy medication, in patients with cryptogenic focal…”
    Get full text
    Journal Article
  5. 5

    MODERN TECHNOLOGIES IN THERAPEUTIC DRUG MONITORING (REVIEW) by D. A. Abaimov, A. K. Sariev, T. Yu. Noskova, V. V. Shvedkov, M. V. Shiryaeva, E. Yu. Styrova, D. I. Prokhorov, R. D. Seyfulla

    “…due to the emergence of new technologies in a pharmakokinetics, a pharmacogenetics and analytical chemistry, the medicine comes to qualitatively new stage of…”
    Get full text
    Journal Article
  6. 6

    The clinical and neurophysiological characteristics of the deja vu phenomenon in epilepsy by P. N. Vlasov, A. V. Chervyakov, G. R. Drozhzhina, М. V. Antonyuk, N. V. Orekhova, V. V. Gnezditsky, T. Yu. Noskova, P. A. Fedin

    “…Objective: to study the clinical and neurophysiological characteristics of the deja vu phenomenon in epilepsy. Patients and methods. The manifestations of the…”
    Get full text
    Journal Article
  7. 7

    Application of Gas Chromatography/Mass Spectrometry to Therapeutic Monitoring of Valproic Acid by Abaimov, D. A., Sariev, A. K., Tyurin, I. A., Prokhorov, D. I., Noskova, T. Yu, Shvedkov, V. V., Seifulla, R. D.

    Published in Pharmaceutical chemistry journal (01-02-2013)
    “…A new method for quantitative determination of the anticonvulsant valproic acid that was based on gas chromatography with mass spectrometric detection of three…”
    Get full text
    Journal Article
  8. 8

    NEW METHODS OF OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY: USE OF BAYESIAN PHARMACOKINETIC MODELING by Z. А. Suslina, А. K. Sariev, D. А. Аbaimov, T. YU. Noskova, R. D. Sejfulla, V. V. Shvedkov, D. I. Prokhorov, M. V. Shiryaeva, L. А. Mota

    “…There was carried out the therapeutic drug monitoring of antiepileptic drug carbamazepine by use of a bayesian mathematical modeling method in 47 patients with…”
    Get full text
    Journal Article